Scientists in America have developed a one-time, gene editing treatment that restored hearing and balance in adult mice with a...
Read moreDetailsA new study has documented “considerable improvement” in all 10 patients who received one injection of gene therapy for congenital...
Read moreDetailsBritish and American researchers have identified new ‘candidate’ genes which they say could be responsible for congenital hearing loss. A...
Read moreDetailsTen of 12 children with profound genetic hearing loss who received Regeneron Pharmaceutical’s gene therapy showed ‘clinically meaningful, notable improvements...
Read moreDetailsThe inherited or genetic form of Ménière’s disease may be more common than first realised, according to Kolling Institute researchers...
Read moreDetailsSensorion has provided gene therapy to two more toddlers with congenital deafness after the first child, an Australian infant, received...
Read moreDetailsEXCLUSIVE: A young child has become the first in Australia to receive pioneering gene therapy for deafness in a groundbreaking...
Read moreDetailsWorld leading Ménière's disease researcher PROFESSOR JOSE ANTONIO LOPEZ-ESCAMEZ moved from Spain to the University of Sydney to establish the...
Read moreDetailsGene therapy is the new frontier in medicine, and the hearing sector is at the forefront. In this feature, we...
Read moreDetailsA Melbourne study is recruiting Australians with auditory neuropathy to undergo genetic testing which could lead to gene therapy in...
Read moreDetails
Hearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited